BioLife Solutions Return on Tangible Equity 2012-2025 | BLFS
Current and historical return on tangible equity values for BioLife Solutions (BLFS) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| BioLife Solutions Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-09-30 | $0.00B | $0.13B | -2.31% |
| 2025-06-30 | $-0.01B | $0.13B | -5.14% |
| 2025-03-31 | $-0.01B | $0.13B | -10.55% |
| 2024-12-31 | $-0.02B | $0.13B | -22.46% |
| 2024-09-30 | $-0.05B | $0.08B | -53.33% |
| 2024-06-30 | $-0.08B | $0.08B | -82.64% |
| 2024-03-31 | $-0.06B | $0.09B | -66.67% |
| 2023-12-31 | $-0.07B | $0.11B | -68.17% |
| 2023-09-30 | $-0.10B | $0.09B | -103.82% |
| 2023-06-30 | $-0.08B | $0.10B | -79.62% |
| 2023-03-31 | $-0.15B | $0.10B | -135.81% |
| 2022-12-31 | $-0.14B | $0.11B | -129.00% |
| 2022-09-30 | $-0.11B | $0.11B | -99.76% |
| 2022-06-30 | $-0.10B | $0.11B | -90.14% |
| 2022-03-31 | $-0.02B | $0.10B | -14.18% |
| 2021-12-31 | $-0.01B | $0.10B | -8.20% |
| 2021-09-30 | $0.01B | $0.11B | 7.05% |
| 2021-06-30 | $0.01B | $0.11B | 5.87% |
| 2021-03-31 | $-0.02B | $0.12B | -16.15% |
| 2020-12-31 | $0.00B | $0.12B | 2.55% |
| 2020-09-30 | $0.00B | $0.13B | 8.60% |
| 2020-06-30 | $0.02B | $0.05B | 70.59% |
| 2020-03-31 | $0.04B | $0.01B | 186.67% |
| 2019-12-31 | $0.00B | $-0.01B | -7.55% |
| 2019-09-30 | $-0.03B | $0.03B | -96.24% |
| 2019-06-30 | $-0.04B | $0.04B | -113.10% |
| 2019-03-31 | $-0.04B | $0.04B | -143.09% |
| 2018-12-31 | $-0.03B | $0.02B | -112.36% |
| 2018-09-30 | $0.00B | $0.04B | 4.76% |
| 2018-06-30 | $0.00B | $0.02B | 0.00% |
| 2018-03-31 | $0.00B | $0.01B | -23.53% |
| 2017-12-31 | $0.00B | $0.01B | -44.44% |
| 2017-09-30 | $-0.01B | $0.01B | -100.00% |
| 2017-06-30 | $-0.01B | $0.01B | -141.18% |
| 2017-03-31 | $-0.01B | $0.00B | -160.00% |
| 2016-12-31 | $-0.01B | $0.00B | -133.33% |
| 2016-09-30 | $0.00B | $0.00B | -69.57% |
| 2016-06-30 | $0.00B | $0.01B | -57.14% |
| 2016-03-31 | $0.00B | $0.01B | -48.48% |
| 2015-12-31 | $0.00B | $0.01B | -42.11% |
| 2015-09-30 | $0.00B | $0.01B | -38.10% |
| 2015-06-30 | $0.00B | $0.01B | -34.78% |
| 2015-03-31 | $0.00B | $0.01B | -32.65% |
| 2014-12-31 | $0.00B | $0.01B | -30.77% |
| 2014-09-30 | $0.00B | $0.01B | -44.44% |
| 2014-06-30 | $0.00B | $0.01B | -800.00% |
| 2014-03-31 | $0.00B | $0.01B | 16.00% |
| 2013-12-31 | $0.00B | $-0.01B | 0.00% |
| 2013-09-30 | $0.00B | $-0.01B | 8.00% |
| 2013-06-30 | $0.00B | $-0.01B | 8.16% |
| 2013-03-31 | $0.00B | $-0.01B | 8.33% |
| 2012-12-31 | $0.00B | $-0.01B | 8.51% |
| 2012-09-30 | $0.00B | $-0.01B | 0.00% |
| 2012-06-30 | $0.00B | $-0.01B | 0.00% |
| 2012-03-31 | $0.00B | $-0.01B | 0.00% |
| 2011-12-31 | $0.00B | $-0.01B | 9.52% |
| 2011-09-30 | $0.00B | $-0.01B | 9.76% |
| 2011-06-30 | $0.00B | $-0.01B | 10.26% |
| 2011-03-31 | $0.00B | $-0.01B | 21.05% |
| 2010-12-31 | $0.00B | $-0.01B | 22.22% |
| 2010-09-30 | $0.00B | $-0.01B | 23.53% |
| 2010-06-30 | $0.00B | $-0.01B | 37.50% |
| 2010-03-31 | $0.00B | $-0.01B | 40.00% |
| 2009-12-31 | $0.00B | $-0.01B | 42.86% |
| 2009-09-30 | $0.00B | $-0.01B | 64.00% |
| 2009-06-30 | $0.00B | $-0.01B | 72.73% |
| 2009-03-31 | $0.00B | $-0.01B | 84.21% |
| 2008-12-31 | $0.00B | $-0.01B | 100.00% |
| 2008-09-30 | $0.00B | $0.00B | 123.08% |
| 2008-06-30 | $0.00B | $0.00B | 145.45% |
| 2008-03-31 | $0.00B | $0.00B | 200.00% |
| 2007-12-31 | $0.00B | $0.00B | 320.00% |
| 2007-09-30 | $0.00B | $0.00B | 400.00% |
| 2007-06-30 | $0.00B | $0.00B | 800.00% |
| 2007-03-31 | $0.00B | $0.00B | -400.00% |
| 2006-12-31 | $0.00B | $0.00B | 0.00% |
| 2006-09-30 | $0.00B | $0.00B | 0.00% |
| 2006-06-30 | $0.00B | $0.00B | 0.00% |
| 2006-03-31 | $0.00B | $0.00B | 0.00% |
| 2005-12-31 | $0.00B | $0.00B | 0.00% |
| 2005-09-30 | $0.00B | $0.00B | 0.00% |
| 2005-06-30 | $0.00B | $0.00B | 0.00% |
| 2005-03-31 | $0.00B | $0.00B | 0.00% |
| 2004-12-31 | $0.00B | $0.00B | 0.00% |
| 2004-09-30 | $0.00B | $0.00B | 0.00% |
| 2004-06-30 | $0.00B | $0.00B | -400.00% |
| 2004-03-31 | $0.00B | $0.00B | 400.00% |
| 2003-12-31 | $0.00B | $0.00B | 133.33% |
| 2003-09-30 | $0.00B | $0.00B | 80.00% |
| 2003-06-30 | $0.00B | $0.00B | 0.00% |
| 2003-03-31 | $0.00B | $0.00B | 400.00% |
| 2002-12-31 | $0.00B | $0.00B | 400.00% |
| 2002-09-30 | $0.00B | $0.00B | 0.00% |
| 2002-06-30 | $0.00B | $0.00B | -400.00% |
| 2002-03-31 | $0.00B | $0.00B | 0.00% |
| 2001-12-31 | $0.00B | $0.00B | -533.33% |
| 2001-09-30 | $-0.01B | $0.00B | -466.67% |
| 2001-06-30 | $-0.01B | $0.00B | -280.00% |
| 2001-03-31 | $-0.01B | $0.00B | -200.00% |
| 2000-12-31 | $-0.01B | $0.00B | -200.00% |
| 2000-09-30 | $0.00B | $0.00B | -177.78% |
| 2000-06-30 | $0.00B | $0.01B | -200.00% |
| 2000-03-31 | $0.00B | $0.00B | -400.00% |
| 1999-12-31 | $0.00B | $0.00B | -200.00% |
| 1999-09-30 | $0.00B | $0.00B | 0.00% |
| 1999-06-30 | $0.00B | $0.00B | 0.00% |
| 1999-03-31 | $0.00B | $0.00B | 0.00% |
| 1998-12-31 | $0.00B | $0.00B | -57.14% |
| 1998-09-30 | $0.00B | $0.00B | -100.00% |
| 1998-06-30 | $0.00B | $0.00B | -88.89% |
| 1998-03-31 | $0.00B | $0.00B | -120.00% |
| 1997-12-31 | $0.00B | $0.00B | -66.67% |
| 1997-09-30 | $0.00B | $0.00B | -28.57% |
| 1997-06-30 | $0.00B | $0.00B | -26.67% |
| 1997-03-31 | $0.00B | $0.00B | -53.33% |
| 1996-12-31 | $0.00B | $0.00B | -50.00% |
| 1996-09-30 | $0.00B | $0.00B | -80.00% |
| 1996-06-30 | $0.00B | $0.00B | -80.00% |
| 1996-03-31 | $0.00B | $0.01B | -50.00% |
| 1995-12-31 | $0.00B | $0.00B | -80.00% |
| 1995-09-30 | $0.00B | $0.00B | -47.06% |
| 1995-06-30 | $0.00B | $0.00B | -44.44% |
| 1995-03-31 | $0.00B | $0.00B | -21.05% |
| 1994-12-31 | $0.00B | $0.01B | -21.05% |
| 1994-09-30 | $0.00B | $0.01B | -42.11% |
| 1994-06-30 | $0.00B | $0.01B | -63.16% |
| 1994-03-31 | $-0.01B | $0.00B | -100.00% |
| 1993-12-31 | $-0.01B | $0.01B | -86.96% |
| 1993-09-30 | $-0.01B | $0.01B | -88.89% |
| 1993-06-30 | $-0.01B | $0.01B | -87.50% |
| 1993-03-31 | $-0.01B | $0.01B | -73.68% |
| 1992-12-31 | $-0.01B | $0.01B | -80.00% |
| 1992-09-30 | $-0.01B | $0.01B | -80.00% |
| 1992-06-30 | $-0.01B | $0.01B | -80.00% |
| 1992-03-31 | $0.00B | $0.00B | -88.89% |
| 1991-12-31 | $0.00B | $0.00B | -100.00% |
| 1991-09-30 | $0.00B | $0.01B | -114.29% |
| 1991-06-30 | $0.00B | $0.01B | -133.33% |
| 1990-12-31 | $0.00B | $0.00B | -66.67% |
| 1990-09-30 | $0.00B | $0.00B | -28.57% |
| 1989-12-31 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.090B | $0.082B |
| BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $193.137B | 21.57 |
| EssilorLuxottica (ESLOY) | France | $140.784B | 0.00 |
| Stryker (SYK) | United States | $136.173B | 26.12 |
| Medtronic (MDT) | Ireland | $130.317B | 18.06 |
| Boston Scientific (BSX) | United States | $109.879B | 24.30 |
| Medline (MDLN) | United States | $62.231B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.151B | 0.00 |
| ResMed (RMD) | United States | $40.201B | 26.84 |
| Agilent Technologies (A) | United States | $36.062B | 22.85 |
| GE HealthCare Technologies (GEHC) | United States | $36.041B | 17.27 |
| Koninklijke Philips (PHG) | Netherlands | $28.522B | 18.63 |
| Terumo (TRUMY) | Japan | $19.692B | 22.25 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.783B | 11.09 |
| Insulet (PODD) | United States | $17.275B | 53.62 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.896B | 0.00 |
| Baxter (BAX) | United States | $11.170B | 9.02 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.955B | 28.60 |
| Demant (WILYY) | Denmark | $6.521B | 0.00 |
| Envista Holdings (NVST) | United States | $4.828B | 24.47 |
| Lantheus Holdings (LNTH) | United States | $4.324B | 13.17 |
| BillionToOne (BLLN) | United States | $4.229B | 0.00 |
| ICU Medical (ICUI) | United States | $3.749B | 23.80 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.092B | 14.59 |
| Haemonetics (HAE) | United States | $2.681B | 11.73 |
| Neogen (NEOG) | United States | $2.308B | 50.52 |
| Phibro Animal Health (PAHC) | United States | $2.102B | 18.52 |
| QuidelOrtho (QDEL) | United States | $1.988B | 12.78 |
| Perrigo (PRGO) | Ireland | $1.971B | 4.94 |
| LeMaitre Vascular (LMAT) | United States | $1.963B | 39.52 |
| AtriCure (ATRC) | United States | $1.836B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.672B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.564B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.452B | 63.64 |
| AdaptHealth (AHCO) | United States | $1.452B | 21.02 |
| Capricor Therapeutics (CAPR) | United States | $1.152B | 0.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.092B | 0.00 |
| InMode (INMD) | Israel | $0.956B | 10.80 |
| Tilray Brands (TLRY) | Canada | $0.897B | 0.00 |
| Valneva SE (VALN) | France | $0.833B | 0.00 |
| Omeros (OMER) | United States | $0.801B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.795B | 0.00 |
| CeriBell (CBLL) | United States | $0.775B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.589B | 15.95 |
| Verano Holdings (VRNO) | United States | $0.469B | 0.00 |
| Brainsway (BWAY) | Israel | $0.442B | 75.20 |
| Cerus (CERS) | United States | $0.419B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
| SNDL (SNDL) | Canada | $0.389B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.387B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.321B | 25.61 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Quanterix (QTRX) | United States | $0.288B | 0.00 |
| Evolus (EOLS) | United States | $0.275B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.226B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.220B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Organigram Global (OGI) | Canada | $0.215B | 0.00 |
| High Tide (HITI) | Canada | $0.213B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.206B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.203B | 59.83 |
| OraSure Technologies (OSUR) | United States | $0.202B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.200B | 17.93 |
| Accendra Health (ACH) | United States | $0.185B | 1.85 |
| Sanara MedTech (SMTI) | United States | $0.177B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.163B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.156B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.143B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.137B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.86 |
| MacroGenics (MGNX) | United States | $0.114B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.103B | 0.00 |
| Biote (BTMD) | United States | $0.100B | 4.40 |
| Exagen (XGN) | United States | $0.076B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.54 |
| Sharps Technology (STSS) | United States | $0.051B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 30.92 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.033B | 0.00 |
| United-Guardian (UG) | United States | $0.032B | 16.30 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.013B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |